The natural history of sclerosteosis
- PMID: 12694228
- DOI: 10.1034/j.1399-0004.2003.00036.x
The natural history of sclerosteosis
Erratum in
- Clin Genet. 2003 Aug;64(2):176
Abstract
Sclerosteosis (SCL) is a severe, progressive, autosomal-recessive craniotubular hyperostosis (MIM 269500). The determinant gene (SOST) has been isolated, and genotype-phenotype correlations, as well as the elucidation of pathogenetic mechanisms, are dependent upon the documentation of the natural history of the condition. For this reason, the course and complications in 63 affected individuals in South Africa, seen over a 38-year period, have been analyzed. Thirty-four of these persons died during the course of the survey, 24 from complications related to elevation of intracranial pressure as a result of calvarial overgrowth. The mean age of death in this group of individuals was 33 years, with an even gender distribution. Facial palsy and deafness, as a result of cranial nerve entrapment, developed in childhood in 52 (82%) affected persons. Mandibular overgrowth was present in 46 (73%) adults and syndactyly in 48 (76%). In South Africa in 2002, 29 affected persons were alive, 10 being < or =20 years of age. It is evident that sclerosteosis is a severe disorder which places a considerable burden upon affected individuals and their families.
Copyright Blackwell Munksgaard, 2003
Similar articles
-
Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.Metabolism. 2018 Mar;80:38-47. doi: 10.1016/j.metabol.2017.10.005. Epub 2017 Oct 25. Metabolism. 2018. PMID: 29080811 Review.
-
A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.Genet Test. 2008 Dec;12(4):475-9. doi: 10.1089/gte.2008.0036. Genet Test. 2008. PMID: 19072561
-
Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.Eur J Med Genet. 2014 Mar;57(4):133-7. doi: 10.1016/j.ejmg.2014.02.007. Epub 2014 Mar 1. Eur J Med Genet. 2014. PMID: 24594238
-
Sclerosteosis - an autosomal recessive disorder.Clin Genet. 1977 Jan;11(1):1-7. doi: 10.1111/j.1399-0004.1977.tb01269.x. Clin Genet. 1977. PMID: 187366
-
The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.Hormones (Athens). 2014 Oct-Dec;13(4):323-37. doi: 10.14310/horm.2002.1552. Hormones (Athens). 2014. PMID: 25555179 Review.
Cited by
-
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders.Front Endocrinol (Lausanne). 2021 Aug 13;12:709711. doi: 10.3389/fendo.2021.709711. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34539568 Free PMC article. Review.
-
Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies.JBMR Plus. 2021 Jun 23;5(7):e10522. doi: 10.1002/jbm4.10522. eCollection 2021 Jul. JBMR Plus. 2021. PMID: 34258509 Free PMC article. Review.
-
Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.Curr Osteoporos Rep. 2020 Feb;18(1):67-80. doi: 10.1007/s11914-020-00564-9. Curr Osteoporos Rep. 2020. PMID: 31953640 Review.
-
Circulating sclerostin in disorders of parathyroid gland function.J Clin Endocrinol Metab. 2011 Dec;96(12):3804-10. doi: 10.1210/jc.2011-0566. Epub 2011 Sep 21. J Clin Endocrinol Metab. 2011. PMID: 21937621 Free PMC article.
-
El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo.Adv Lab Med. 2023 Sep 22;5(1):35-45. doi: 10.1515/almed-2023-0101. eCollection 2024 Mar. Adv Lab Med. 2023. PMID: 38634083 Free PMC article. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous